ACE and cancer: Cancer cells with high CTSE expression promote the upregulation of DCP in HCC by suppressing ubiquinone signaling activation and regulating the redox capacity of vitamin K. The release of DCP from HCC cells is a key regulatory factor in forming a T cell-depleted tumor immune microenvironment.